Neola Medical AB (publ) (STO:NEOLA)
Sweden · Delayed Price · Currency is SEK 0.6450
-0.0100 (-1.53%)
Jul 24, 2026, 12:24 PM CET
Neola Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 9.01 | 8.33 | 10.39 | 9.83 | 9.75 | 11.1 | |
Revenue Growth (YoY) | -1.02% | -19.86% | 5.73% | 0.85% | -12.21% | 279.78% |
Cost of Revenue | 0.2 | 0.27 | 1.37 | 1.77 | 1.42 | 1.33 |
Gross Profit | 8.82 | 8.05 | 9.02 | 8.06 | 8.32 | 9.77 |
Selling, General & Admin | 19.39 | 17.76 | 18.23 | 16.09 | 17.64 | 16.39 |
Depreciation & Amortization Expenses | 1.42 | 1.39 | 1.53 | 1.59 | 1.04 | 0.02 |
Other Operating Expenses | - | 0 | 0.06 | 0 | 0.03 | 0.02 |
Total Operating Expenses | 20.8 | 19.15 | 19.82 | 17.69 | 18.71 | 16.42 |
Operating Income | -11.99 | -11.09 | -10.8 | -9.62 | -10.39 | -6.65 |
Total Non-Operating Income (Expense) | 0.04 | 0.07 | 0.73 | 0.61 | 0.03 | 0 |
Pretax Income | -11.95 | -11.02 | -10.06 | -9.01 | -10.35 | -6.65 |
Net Income | -11.95 | -11.02 | -10.06 | -9.01 | -10.35 | -6.65 |
Net Income to Common | -11.95 | -11.02 | -10.06 | -9.01 | -10.35 | -6.65 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 78 | 76 | 70 | 56 | 26 | 14 |
Shares Outstanding (Diluted) | 78 | 76 | 70 | 56 | 26 | 14 |
Shares Change (YoY) | 10.64% | 8.93% | 25.80% | 113.90% | 86.03% | 48.67% |
EPS (Basic) | -0.16 | -0.14 | -0.14 | -0.17 | -0.40 | -0.47 |
EPS (Diluted) | -0.16 | -0.14 | -0.14 | -0.17 | -0.40 | -0.47 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -12.67 | -9.78 | -9.32 | -6.54 | -8.6 | -7.1 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.16 | -0.13 | -0.13 | -0.12 | -0.33 | -0.51 |
Gross Margin | 97.83% | 96.71% | 86.83% | 82.04% | 85.41% | 88.02% |
Operating Margin | -133.00% | -133.20% | -103.91% | -97.88% | -106.57% | -59.93% |
Profit Margin | -132.61% | -132.35% | -96.84% | -91.67% | -106.23% | -59.93% |
FCF Margin | -140.59% | -117.39% | -89.69% | -66.56% | -88.24% | -63.98% |
EBITDA | -11.99 | -9.84 | -9.27 | -9.62 | -10.39 | -6.65 |
EBITDA Margin | -133.00% | -118.18% | -89.21% | -97.88% | -106.57% | -59.93% |
EBIT | -11.99 | -11.09 | -10.8 | -9.62 | -10.39 | -6.65 |
EBIT Margin | -133.00% | -133.20% | -103.91% | -97.88% | -106.57% | -59.93% |